Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Medicinal Chemistry|January 7, 2017
Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with MiltefosineDevireddy Anand, Pawan Kumar Yadav, Om P S Patel, et al.
Virus Research|January 27, 2024
Aged AG129 mice support the generation of highly virulent novel mouse-adapted DENV (1-4) viruses exhibiting neuropathogenesis and high lethalityGazala Siddqui, Preeti Vishwakarma, Shikha Saxena, et al.
The Journal of Biological Chemistry|August 21, 2020
Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivoSweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
Frontiers in Immunology|April 12, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitroPreeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, et al.
Vaccine|May 10, 2026
Comparative immunogenicity of monomeric and tetrameric Nipah virus G glycoprotein-based vaccine candidates demonstrate robust antibody responses in both formsSurbhi Mishra, Varun Kumar, Gurleen Kaur, et al.
The Journal of Biological Chemistry|July 31, 2020
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic libraryHilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Aminothiazoles: Hit to lead development to identify antileishmanial agentsDebnath Bhuniya, Rao Mukkavilli, Rahul Shivahare, et al.
NPJ Vaccines|December 26, 2025
Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunityHima Bindhu, Srabanti Rakshit, Vasista Adiga, et al.
European Journal of Medicinal Chemistry|October 8, 2013
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agentsVadiraj S Gopinath, Jakir Pinjari, Ravindra T Dere, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Pageof 4